3Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
4Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
5Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
6Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
3Shiraki K,Fujikawa K,Sugimoto K,et al.Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma[J].Int J Mol Med,2006,18(1):77-81.
